2 results
Approved WMOPending
To evaluate the efficacy and safety of nilotinib in spondyloarthritis
Approved WMOWill not start
To examine the effect of L-dopa addition to optimal D2-blocking antipsychotic treatment on positive symptoms, negative symptoms, cognitive symptoms and extrapyramidal symptoms in schizophrenia.